Umbilical Cord News and Research

RSS

The umbilical cord is the structure that attaches the fetus to the placenta and acts as the medium through which nutrients, gases and waste products travel between the mother and the fetus.

Study finds abnormal fetal circulation as a risk factor for fetal thrombotic vasculopathy

Examination of the placenta can offer answers to the questions that arise following an adverse perinatal outcome, such as stillbirth or intrauterine growth restriction. A placental lesion known as fetal thrombotic vasculopathy (FTV) has been associated with a number of adverse outcomes. By studying placentas with this lesion, researchers hope to determine the risks of such serious complications that affect fetuses and newborns.

19 Apr 2011

Organic pollutants in flame retardents cause molecular changes in reproductive organs

Polybrominated diphenyl ethers (PBDEs) are chemicals that have been widely used as flame retardants and are now classified as persistent organic pollutants. Health concerns in humans have arisen based primarily on studies with laboratory animals exposed to high levels of PBDEs. Three commercial mixtures of PBDEs have been manufactured in or imported into the United States which include penta-, octa-, and deca-brominated diphenyl ethers (BDEs).

15 Apr 2011

Obesity and smoking linked to stillbirths: Report

According to experts, excessive weight, smoking and late maternal age over 35 are contributing to thousands of stillbirths each year in high-income countries, including Australia, and the trend looks set to continue. These figures were published in the Lancet medical journal.

13 Apr 2011

Early uMSC transplantation may treat lupus nephritis

Human umbilical cord blood-derived mensenchymal stem cells have been found to offer benefits for treating lupus nephritis when transplanted into mouse models of systemic lupus erythematosus.

12 Apr 2011

Court grants motion to dismiss Cryo-Cell International lawsuit against Cord Blood America

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that the Pinellas County Circuit Court granted a motion to dismiss the lawsuit filed by Cryo-Cell International against Cord Blood America, which CBAI management believed was an attempt to inhibit the pending deal between Cryo-Cell Mexico and CBAI.

5 Apr 2011

CBAI partners with BlueCross and offers cord blood banking services to their members

Cord Blood America, Inc., announced today it has entered into an agreement with BlueCross BlueShield of Tennessee and is now offering the storage of umbilical cord blood at a discount rate as consistent with its other BCBS licensee contracts.

28 Mar 2011

CBAI to operate its own business strategies

17 Mar 2011

Beike, ThermoGenesis enter agreement to employ new technology for stem cell therapies

Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced an agreement with USA-based ThermoGenesis Corp. to employ new, cutting edge stem cell processing and storage technology across its adult stem cell collection, processing, and archive platform.

17 Mar 2011

Sanfilippo syndrome compromises blood-brain barrier, leads to brain damage

A study into the effects of Sanfilippo Syndrome type B (MPS III B) has found that the barrier responsible for protecting the brain from the entry of harmful blood-borne substances is structurally and functionally damaged by the devastating disease. University of South Florida researchers identified damage in specific brain structures involved in the pathology of MPS III B, one of four Sanfilippo syndromes, all of which are inherited diseases of metabolism.

9 Mar 2011

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Transplanting stem cells derived from umbilical cord blood cells and menstrual blood cells may offer future therapeutic benefit for those suffering from stroke, Alzheimer's disease, and amyotrophic lateral sclerosis, says a team of neuroscience researchers from the University of South Florida's Department of Neurosurgery and Brain Repair and collaborators from three private-sector research groups, Saneron CCEL Therapeutics, Inc., Tampa, FL, Cryo-Cell International, Inc., Oldsmar, FL, and Cryopraxis, Cell Praxis, BioRio, Rio de Janeiro, Brazil.

8 Mar 2011

CBAI modifies authorized shares from pro-rata 500 to 250 million

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that the Company's management team and board of directors has modified the proposed one share for each 500 outstanding shares reverse stock split to one share for each 100 outstanding shares.

4 Mar 2011

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

A consortium of thirty-two researchers worldwide, led by Dr Jordi Surrallés, professor of the Department of Genetics and Microbiology at Universitat Autònoma de Barcelona (UAB) and member of the Centre for Biomedical Network Research on Rare Diseases (CIBERER), genetically and clinically characterised almost all Spanish patients suffering from Franconi anaemia, a rare disease affecting one in every 500,000 persons and which is characterised by severe anaemia in children, congenital malformations and a high predisposition to cancer.

3 Mar 2011

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company, focused on bringing the life saving potential of cord blood stem cells to families nationwide and internationally, announced today that it has purchased all the umbilical cord blood samples and the related laboratory equipment from Reproductive Genetics Institute, Inc., based in Chicago, Illinois.

2 Mar 2011

Human umbilical cord blood-derived EPCs accelerate wound healing in diabetics

Transplanting human umbilical cord blood-derived endothelial progenitor cells (EPCs) has been found to "significantly accelerate" wound closure in diabetic mouse models, said a team of Korean researchers publishing in the current issue of Cell Transplantation.

23 Feb 2011

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Fate Therapeutics, Inc. presented encouraging preliminary data from an ongoing Phase 1b clinical trial of FT1050 at the 2011 BMT Tandem Meetings in Honolulu, Hawaii.

22 Feb 2011

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Corifact™, Factor XIII Concentrate (Human), for the routine prophylactic treatment of congenital factor XIII (FXIII) deficiency. Corifact, already available for use in 12 countries throughout the world under the trade name Fibrogammin®- P, is the first and only FXIII concentrate approved in the U.S.

19 Feb 2011

TI Pharma launches new research project on stem cell transplant

Top Institute Pharma is today launching a new research project that should make stem cell transplants more successful. A stem cell transplant is usually performed on adults with acute leukemia.

18 Feb 2011

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.

18 Feb 2011

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.

18 Feb 2011

Cord Blood America purchases minority interest in Stem Cells VIDAPLUS

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it has purchased a minority interest in Stem Cells VIDAPLUS, a Spanish-owned company which preserves umbilical cord stem cells at the Institute of Transfusion Medicine and Immunology of the Red Cross in Frankfurt, Germany.

14 Feb 2011

Umbilical Cord News and Research

Further Reading

Study finds abnormal fetal circulation as a risk factor for fetal thrombotic vasculopathy

Organic pollutants in flame retardents cause molecular changes in reproductive organs

Obesity and smoking linked to stillbirths: Report

Early uMSC transplantation may treat lupus nephritis

Court grants motion to dismiss Cryo-Cell International lawsuit against Cord Blood America

CBAI partners with BlueCross and offers cord blood banking services to their members

CBAI to operate its own business strategies

Beike, ThermoGenesis enter agreement to employ new technology for stem cell therapies

Sanfilippo syndrome compromises blood-brain barrier, leads to brain damage

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

CBAI modifies authorized shares from pro-rata 500 to 250 million

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Human umbilical cord blood-derived EPCs accelerate wound healing in diabetics

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

TI Pharma launches new research project on stem cell transplant

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

Cord Blood America purchases minority interest in Stem Cells VIDAPLUS

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News